Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 32: 342-346, 1986;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cederblad, G.
Right arrow Articles by Lindgren, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cederblad, G.
Right arrow Articles by Lindgren, K.

Clinical Chemistry, Vol 32, 342-346, Copyright © 1986 by American Association for Clinical Chemistry

Spectrophotometry of carnitine in biological fluids and tissue with a Cobas Bio centrifugal analyzer

G Cederblad, P Harper and K Lindgren

A spectrophotometric method for carnitine has been adapted to the Cobas Bio centrifugal analyzer. The addition of carnitine to a system containing carnitine acetyltransferase (EC 2.3.1.7) and acetyl-CoA gives rise to the formation of CoA. The system is coupled to 5,5'- dithiobis(2-nitrobenzoate) (DTNB). Assay response varied linearly with concentration of carnitine over a wide concentration range. The total CV was 5.5% for a carnitine concentration in serum of 58.0 mumol/L. Analytical recovery of carnitine added to a serum sample was 93%. No interference was found in icteric, not grossly hemolyzed, lipemic, or uremic sera. Comparison with a radioenzymatic method showed that results correlated well (r greater than 0.965) but the present method gave values proportionally greater by 10 to 25% for samples of plasma, dialysis fluid, urine, and muscle tissue. Advantages over the original spectrophotometric assays involving DTNB include low reagent costs, rapidity, simplicity, and reproducibility. However, this modification is not as sensitive and probably not as specific as the radioenzymatic methods.


The following articles in journals at HighWire Press have cited this article:


Home page
 Mult SclerHome page
C Lebrun, H Alchaar, M Candito, V Bourg, and M Chatel
Levocarnitine administration in multiple sclerosis patients with immunosuppressive therapy-induced fatigue
Multiple Sclerosis, June 1, 2006; 12(3): 321 - 324.
[Abstract] [PDF]

Home page
 Nephrol Dial TransplantHome page
F. Kokot, W. Lysiak-Szydlowska, M. Adamczak, J. Chudek, W. Ignacy, B. Rutkowski, R. Ficek, and A. Wiecek
Are plasma concentrations of leptin and carnitineinterrelated in haemodialysis patients?
Nephrol. Dial. Transplant., February 1, 2001; 16(2): 434 - 435.
[Full Text] [PDF]

Home page
 NeurologyHome page
I. Tein, R. H. A. Haslam, W. J. Rhead, M. J. Bennett, L. E. Becker, and J. Vockley
Short-chain acyl-CoA dehydrogenase deficiency: A cause of ophthalmoplegia and multicore myopathy
Neurology, January 1, 1999; 52(2): 366 - 366.
[Abstract] [Full Text]

Home page
 Clin. Chem.Home page
L. Wan and R. W. Hubbard
Determination of free and total carnitine with a random-access chemistry analyzer
Clin. Chem., April 1, 1998; 44(4): 810 - 816.
[Abstract] [Full Text] [PDF]

Home page
 JPEN J Parenter Enteral NutrHome page
J. Maeda and S. J. Dudrick
Rapid Spectrophotometric Determination of Plasma Carnitine Concentrations
JPEN J Parenter Enteral Nutr, September 1, 1990; 14(5): 527 - 532.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1986 by the American Association for Clinical Chemistry.